Bright Peak Therapeutics
Allschwil
About Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $232.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2024)
- Website: brightpeaktx.com
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bright-peak-therapeutics-61690 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.